Trial Profile
Double Blinded, Randomized, Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2022
Price :
$35
*
At a glance
- Drugs PG 201 (Primary) ; Celecoxib
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 19 Apr 2012 New trial record